Metrics Survey of Industry-Sponsored Clinical Trials in Canada and Comparator Jurisdictions between 2005 and 2010

Healthcare policy

Jean-Marie Leclerc¹ 

关键词: Industry-sponsored clinical trials;    international ranking;    trends over time;    performance metrics;    competitiveness;    coordinated policies;    pharma;   

DOI  :  10.12927/hcpol.2012.23130

学科分类：地球科学(综合)

来源: Longwoods Publishing Corp.

【 摘 要 】

Industry-sponsored clinical trials play a key role in the development of therapies. This survey suggests that between 2005 and 2010, research-based pharmaceutical firms worldwide initiated fewer trials and recruited fewer subjects annually. In contrast, at the country level, the clinical trial activity of such firms increased in emerging countries and in Japan. Canada's trend in the number of new trials followed that of the global industry, but the trend in new sites and newly recruited subjects fell below the global rate. Informal comparisons point to potential issues for Canada in such areas as site capacity, cost per subject and time to first subject-in. When compared to certain Western European countries and the United States, Canada remained well positioned on a number of metrics. Nonetheless, Canada faces mounting challenges from both traditional locations and emerging countries and may require coordinated efforts to remain a place of choice to conduct trials.

【 授权许可】

Unknown